The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages

Activity: Talk or presentationTalk or presentation at a conference

Period16 Oct 2023
Event title5th Research Day in Tumor Immunology and Immunotherapy
Event typeConference
LocationLeuven, Belgium
Degree of RecognitionNational